Smart Retinal Implants Market Size Analysis, Growth Trends & Forecast to 2034

Smart Retinal Implants Market Overview 

The global smart retinal implants market was valued at USD 0.04 billion in 2026 and is projected to reach USD 0.11 billion by 2034, expanding at a CAGR of 12.7% during the forecast period.  The smart retinal implants market is gaining momentum with the improving influence of innovative technologies in the field of neuroprosthetics, microelectronics, AI, and bioengineering, focusing on the recovery of some vision in patients suffering from serious retinal disorders (e.g., retinitis pigmentosa and advanced AMD). The Smart Retinal Implants are made with the help of implantable networks of electrodes, visual systems, and radio technologies, as well as external visual processing systems for stimulating retinal neurons that remain after the disease to enhance one’s sight ability. There are several factors facilitating the growing demand for these medical devices. There have also been advanced developments of devices due to such factors as increasing rates of incidence of hereditary diseases of the retina, raising levels of investments in the field of ophthalmology, and the fulfillment of more clinical trials of modern retinal prostheses. Moreover, the integration of different technologies works effectively and improves the functioning of devices and the performance of wounded patients, as well as making devices safer in the long term. At the same time, there are several issues (e.g., high prices and the number of patients who can undergo the surgical procedure to receive such devices). 

Smart Retinal Implants Market Drivers and Opportunities

Rising Prevalence of Retinal Degenerative Diseases and Vision Loss is Driving Market Growth

Retinal degenerative diseases and vision loss are the main reasons behind the boost in the smart retinal implants market. With the increase in population aging, prevalence of diabetes, and increases in life expectancy, complications that arise due to aging, like age-related macular degeneration (AMD), diabetic retinopathy (DR), diabetic macular edema (DME), retinal vein obstruction (RVO), and inherited retinal disorders, have become quite frequent. As a result of the mentioned maladies, progressive and irreversible vision loss occurs, and innovative vision restoration technologies, like smart retinal implants, are gaining traction in the market. The implantable neuroprosthetic devices can be considered an effective medical option for advanced retinal degeneration patients suffering from limited or no alternatives in the treatment of their illnesses. Supporting this trend, a March 2026 study published in JAMA Ophthalmology has reported the existence of a substantial burden of retinal diseases in the United States. In accordance with the results of the study, the age-standardized rates of the diseases are as follows: age-related macular degeneration (AMD), 5,677 cases per 100,000 population; diabetic retinopathy (DR), 2,710; diabetic macular edema (DME), 317; retinal vein occlusion (RVO), 214. The study pointed out that the burden of the diseases is more serious among males and varies with respect to race and geographic location. It has been estimated that by 2022, there will be 21.9 million adults aged 40 and older suffering from AMD, reflecting a crude prevalence of 13.6%, while 10 million adults suffer from diabetic eye disease, including approximately 1.8 million having the threatening vision disease. Additionally, around 1.1 million people are suffering from DME, and about 0.9 million are suffering from RVO. The growing number of patients with serious retinal damage and vision loss gives hope for the expansion of advanced retinal prostheses, which results in further research, adoption, and commercialization of smart retinal implants.

Technological Advancements in Retinal Prosthetics and Neurostimulation Fueling Market Expansion

The development of retinal prosthetics and neurostimulation technology is considerably enhancing the efficiency, safety, and clinical effectiveness of modern retinal prostheses, creating the possibility of restoring limited vision in patients with serious retinal diseases. The advancement of microelectronics, dense matrices of electrodes, wireless communication, and biocompatible materials has made it possible to design small, reliable, and highly accurate retinal prostheses that have excellent visual performance and work for longer periods of time. Simultaneously, the combination of artificial intelligence (AI)-based image processing systems and advanced computer vision algorithms enables external cameras to adapt visual signals in real time, enhancing object recognition and navigation abilities. The progression of wireless power transmission technology and low-power electronics is decreasing the complexity of the hardware and incurring fewer potential complications with regard to infection due to the external devices and increasing comfort for the patient. All these advances, together with the optimization of the minimally invasive surgical techniques and the personalization of the neuromodulation processes, allow for more accurate placement of the implant, easier performance of the procedure itself, and better results after the surgery. Research in the area of flexible bioelectronics, photovoltaic retinal prostheses, closed-loop stimulation, brain-retina interface technologies, and other areas focused on bioelectronics will help further increase the capabilities of the future generations of smart retinal prostheses. In the end, thanks to those advances, clinicians become more confident, the eligibility criteria are broadened, and the commercialization and implementation of various smart retinal implants are proceeding faster than ever.

Integration of AI and Next-Generation Bionic Vision Technologies Presents Significant Opportunities

There are great opportunities in the smart retinal implants market due to the advancement of artificial intelligence (AI), computer vision, and sophisticated neuroprosthetic technologies. Image processing through AI can help increase contrast, identify faces and objects, improve edge detection, and improve the visual information before being transmitted to retinal implants, thus enabling patients suffering from degenerative disorders of the retina to experience, among many others, improved functional vision. Together with new inventions of high-density electrode arrays, wireless power supply, biocompatible materials, and closed-loop neurostimulation systems, these new accomplishments are set to narrow down the gap in visual quality and device functioning. One prominent study includes joint projects of the Bionics Institute, the Centre for Eye Research Australia (CERA), CSIRO, and the Australian National University (ANU) in the research of a bionic eye for patients suffering from retinitis pigmentosa. The system consists of a retinal implant, along with a video camera included in smart glasses, and the images are converted to electrical impulses that are sent to the retinal cells using the 44-electrode implant. With the development of AI technologies for such innovative generation bionic vision systems, it can be expected to achieve personalized image enhancement and adaptive vision processing, which will allow the smart retinal implants market to grow significantly.

Smart Retinal Implants Market Scope

Smart Retinal Implants Market Report Segmentation Analysis

The global smart retinal implants market industry analysis is segmented by product type, by implant platform, by disease indication, by end user, and by region. 

Subretinal Implants Segment Is Expected to Dominate the Smart Retinal Implants Market During the Forecast Period

 The subretinal implants segment will dominate the market for smart retinal implants through the forecast period, and this is due to the ability of these implants to stimulate retinal cells that remain in the pathway of vision, thus allowing physiological vision and better performance. These implants are increasingly recommended for the treatment of various retinal degeneration disorders such as AMD and retinitis pigmentosa, thanks to advances in technologies used for miniaturization, wireless energy transfer, biocompatible materials, and high-resolution photovoltaic elements. Their minimally invasive design and the fact that they are compatible with external devices for capturing images result in their popularity and considerably improve the comfort of patients and the effectiveness of their use. The segment's growth is further enabled by substantial product developments and regulatory approvals. For example, in July 2026, Science Corporation announced the commercial launch of PRIMA in Europe--the first and only therapy shown in clinical trials to restore normal central vision in patients with complete or partial geographic atrophy (GA) secondary to AMD. After obtaining CE Mark approval according to the EU Medical Device Regulation, PRIMA became commercially available in 30 countries in Europe. The PRIMA system is based on a very thin photovoltaic implant placed in the subretinal space, which works wirelessly with specialized smart glasses to transmit infrared light to the implant and cause electrical activation of retinal tissue. Wireless integration and utilizing "zoom-in" capability for better letter recognition are the chief advantages of subretinal implants and contribute to maintaining the leadership position and the positive growth dynamics of the subretinal implant segment throughout the forecast period.

Wireless Systems Segment Is Expected to Lead the Smart Retinal Implants Market by Implant Platform

During the forecast period, the wireless systems segment is anticipated to dominate the smart retinal implants market due to the latest technology developments enhancing the efficiency of the devices, comfort for patients, and favorable treatment results over a long period. Operating differently from the wired ones, the wireless retinal implants do not use transdermal wires and external connectors, eliminating the chances of infections or mechanical failures and improving the patient's quality of life. The rise in investments for innovative neuroprosthetics propels wireless technologies even farther. The latest retinal implants begin to combine wireless technologies with cutting-edge artificial intelligence-based image analysis, photovoltaic stimulation, and closed-loop neurostimulation for better visual information transfer and stimulation pattern improvement. Wireless implantable retinal prosthesis creations, as well as advancements in batteryless power transmission, biocompatible materials, and compact size of implants, open more application horizons for smart retinal implants in the treatment of retinitis pigmentosa and age-related macular degeneration. Being at the forefront of technology development and focusing on minimally invasive, fully integrated wireless systems with advanced durability and usability, manufacturers are paving the way for the dominance of wireless systems in the market.

Retinitis Pigmentosa Segment Is Expected to Lead the Smart Retinal Implants Market by Disease Indication 

The segment for retinitis pigmentosa (RP) is likely to dominate the smart retinal implants industry throughout the forecast period, driven by the disease's prevalence, significant unmet demand, and the appropriateness of retinal implant technologies for individuals with severe photoreceptor degeneration. RP is a progressive hereditary retinal disease, affecting rods and cones while leaving intact parts of the inner retinal neural apparatus. Such peculiarities render patients exactly what they need for retinal prostheses aimed at electrostimulating the remaining retinal cells. The lack of large-scale curative approaches and the emergence of new technologies in retinal neuroprosthesis, wireless implants, and artificial intelligence contribute to the growing popularity of smart retinal implants among this category of patients. The considerable prevalence of this condition plays a role in driving the segment's leadership. As per MedlinePlus, retinitis pigmentosa represents one of the most widely seen inherited diseases of the retina, with a prevalence rate of around 1 in 3500 to 1 in 4000 in Europe and the USA. The progressive nature of the disease, which leads to poor vision, ultimately leads to increasing research and commercial ventures in the field of modern bionic eyeball production. Development work on the high-density retinal implant with wireless communication and advanced features will promote improved access and outcomes in terms of treatment in the future.

Hospitals and Ophthalmic Surgery Centers Segment Is Expected to Lead the Smart Retinal Implants Market by End User

Based on their end-user capacity, the hospitals and ophthalmic centers segment is predicted to lead its peers in the smart retinal implants sector during the forecast period. This prediction is due to the very arcane nature of procedures involving retinal implants and the requirement for advanced clinical infrastructure to better manage the patients being considered for these surgeries. Smart retinal implant surgery consists of complex vitreoretinal surgery, advanced diagnostic imaging, and multiple fields of expertise and requisite ways: retinal surgeons, ophthalmologists, neurologists, rehabilitation practitioners, and biomedical engineers work cooperatively on the same surgery. Hospitals and specialized ophthalmic centers possess appropriately furnished operating rooms, OCTs, fundus imaging systems, electrophysiology facilities, and rehabilitation premises, which makes them preferable places for conducting retinal implants. The segment is likely to be bolstered by an increase in the number of clinical trials, regulatory-approved implantation programs, and advanced techniques for vision restoration at tertiary hospitals and specialized eye centers. They offer comprehensive patient assessment, surgery, device programming, visual rehabilitation, and follow-up, which are essential for achieving perfect efficiency in visual functioning. Growing investments in ophthalmic facilities, the opening of specialized centers for retinal surgery, and increasing cooperation between medical institutions and manufacturers of medical devices are expected to lead to better accessibility of advanced retinal implants. As the use of AI-based wireless and minimally invasive retinal prosthesis becomes more widespread, hospitals and ophthalmic centers are likely to remain the main users of the technology throughout the forecast period despite increasing competition.

The following segments are part of an in-depth analysis of the global Smart Retinal Implants Market:

Smart Retinal Implants Market Share Analysis by Region

North America is projected to hold the largest share of the global smart retinal implants market over the forecast period  

During the forecast period, North America is expected to dominate the global market for smart retinal implants, thanks to having an advanced healthcare system, a concentration of top makers of medical devices, and the introduction and rapid use of new technologies in eye care. The region is successful because of high spending on research and development, generous funding of vision restoration programs, and the presence of a completely developed ecosystem made of educational institutions, specialized hospitals, and biotech companies dealing with retinal implants and BCI. Furthermore, the increasing incidence of retinal diseases, including retinitis pigmentosa and wet macular degeneration, as well as the rising knowledge about new therapies, will continue to make the market grow. America is leading the way in smart retinal implant technology due to successful trials of new technologies that support the existence of such revolutionary devices. Companies and researchers from the U.S. and Canada develop the latest wireless retinal implant technology, image processing technologies based on artificial intelligence, photovoltaic eye prostheses, and minimally invasive systems. The availability of reputable institutions conducting research on retinas, successful cooperation between hospitals and IT developers, and the affordability of commercializing implants will boost the usage of smart retinal implants in America over the next few years.

Smart Retinal Implants Market Competition Landscape Analysis

The smart retinal implant market competitors include medical device companies, neurosurgical companies, ophthalmic technology firms, and research-based innovators involved in developing advanced retinal prostheses and bionic vision systems for eyesight restoration in cases of retinal diseases. Companies are competing through incremental innovations in wireless implanted platforms, high-density electrodes, AI technologies for image processing, photovoltaic stimulation systems, and minimally invasive implantation techniques. Strategic activities like research agreements, clinical trials, regulatory approvals, product development, and active partnerships with academia and the healthcare sector are allowing participants to enhance their position in the market.

Global Smart Retinal Implants Market Recent Developments News:

●        In July 2026  - Science Corp. announced the European Commercial launch of PRIMA, the only treatment to restore functional central vision to patients with geographic atrophy caused by age-related macular degeneration, a leading cause of blindness.

●        In July 2026 - The US Food and Drug Administration allowed the startup to pursue a humanitarian device exemption pathway, which is intended for products that address rare conditions and offers a streamlined route to approval.

●        In October 2025 - A wireless retinal implant can restore central vision in patients with advanced age-related macular degeneration (AMD), according to clinical trial results published in the New England Journal of Medicine.

The global smart retinal implants market is dominated by a few large companies, such as

●        Bionic Vision Technologies Pty Ltd

●        Boston Scientific Corporation

●        GenSight Biologics SA

●        iBionics Inc.

●        Intelligent Implants GmbH

●        Labtician Ophthalmics, Inc.

●        LambdaVision, Inc.

●        Nano Retina Ltd.

●        NIDEK CO., LTD.

●        Ocumetics Technology Corporation

●        Ophthorobotics AG

●        Optobionics Corporation

●        Pixium Vision SA

●        Retina Implant AG

●        Science Corporation

●        Second Sight Medical Products, Inc.

●        VisionCare Ophthalmic Technologies, Inc.

●        Vivani Medical

●        Other Prominent Players